chr8-38819879-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006283.3(TACC1):āc.635A>Gā(p.Asp212Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000601 in 1,614,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006283.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TACC1 | NM_006283.3 | c.635A>G | p.Asp212Gly | missense_variant | 3/13 | ENST00000317827.9 | NP_006274.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TACC1 | ENST00000317827.9 | c.635A>G | p.Asp212Gly | missense_variant | 3/13 | 1 | NM_006283.3 | ENSP00000321703.4 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000843 AC: 21AN: 249242Hom.: 0 AF XY: 0.0000666 AC XY: 9AN XY: 135176
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461686Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 727144
GnomAD4 genome AF: 0.000263 AC: 40AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2021 | The c.635A>G (p.D212G) alteration is located in exon 3 (coding exon 3) of the TACC1 gene. This alteration results from a A to G substitution at nucleotide position 635, causing the aspartic acid (D) at amino acid position 212 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at